Terms ending in 2043
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,427,159 | Hydroxypyrrolidine-Substituted Arylsulfonamide Compounds with Selective Activity in Voltage-Gated Sodium Channels In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,559,491 | Modified Imidazopyridines as Glucosylceramide Synthase Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,630,559 | SPIROCYCLIC-SUBSTITUTED 6,7-Dihydro-PYRANO[2,3-d]PYRIMIDINE INHIBITORS OF KRAS G12C MUTANT In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,492,183 | Tetrahydroquinazoline Derivatives as Selective Cytotoxic Agents In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,773,391 | Lipid Nanoparticle Compositions Containing Monoester Cationic Lipids In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,559,514 | Synthesis of Fluorinated Nucleotides In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,497,362 | Cyclopentapyrrole Orexin Receptor Agonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,595,248 | PRMT5 Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,595,262 | PRMT5 Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 12,534,458 | Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 35 more term ends in 2043 · Pro | |||||
10 of 45 patents shown. Soonest term end first, then patent number.
Pro members see all 45.
44 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.